Matrixx Keeps “Pre-Cold” With NAD Ad Victory
This article was originally published in The Tan Sheet
Executive Summary
Matrixx’s use of “The Pre-Cold Medicine” in the context of the challenged ads does not “reasonably convey a message that Zicam is effective in preventing colds or should be used by consumers for that purpose,” the National Advertising Review Board says.
You may also be interested in...
Boots' Symptoms Claim For Dual Defence Not A Prevention Pitch – UK Regulator
Boots UK’s display ad for its Dual Defense cold and flu symptom nasal spray was unlikely to deceive consumers to think it could prevent infection, UK Advertising Standards Authority says, which found that text in a poster ad sufficiently "conceptualized" the claim.
Supplement Claims On Duration Of Cold, Menopausal Support Fail In UK Reviews
The Advertising Standards Authority says Swedish firm Enymatica misses the mark for supporting ColdZyme supplement claims and UK firm PharmaCare’s ads for the Promensil menopause symptoms supplement run afoul of the rule it cites as support.
Zicam Creates A Monster With Reanimated Brand
Matrixx aims to make more consumers aware they can shorten the duration of a cold rather than treat the symptoms without affecting how long the cold lasts. New advertising introduces the “Cold Monster” to remind consumers to use Zicam products when they feel the first signs of a “monster of a cold.”